Perimeter's Imaging Technology Showcased at Osteopathic Surgeons Assembly

Perimeter's Cutting-Edge Imaging Technology at the Annual Clinical Assembly

In a significant move towards revolutionizing cancer surgery, Perimeter Medical Imaging AI, Inc. participated in the 2025 Annual Clinical Assembly of the American College of Osteopathic Surgeons, held from September 17-21 in Salt Lake City, Utah. Dr. Amelia Tower, a leading breast surgical oncologist, showcased the company's innovative wide-field optical coherence tomography (OCT) during breast-conserving surgeries, aiming to reduce unnecessary re-excisions and enhance surgical accuracy.

The focus of Dr. Tower's presentation, titled "Use of Adjunct Wide-field Optical Coherence Tomography to Visualize Margins During Breast Conserving Surgery: A Case Series," highlighted the real-world application of Perimeter’s S-Series OCT device. This technology, which gained FDA clearance in 2021, offers a critical imaging solution to allow surgeons to view tissue margins in real-time, thereby aiding in precise surgical decision-making.

Dr. Tower emphasized a critical issue in breast surgery: many procedures need to be redone because surgeons lack effective tools for assessing the extent of disease at a cellular level during operations. "When re-excisions are necessary, patients experience heightened stress and delays in their recovery process," she stated. This insight underscores the need for surgical tools that can provide immediate feedback on margins, which can significantly impact patient outcomes.

The S-Series OCT technology stands out for its ability to deliver ultra-high-resolution, real-time images that can improve surgical tactics and reduce the chances of disease being left behind after surgery. Surgeons, using this device, can achieve much-needed clarity when making critical decisions in the operating room.

Additionally, Dr. Tower’s presentation is part of a broader effort to communicate the importance of margin visualization and consistent integration of advanced imaging technologies in surgical workflows. As a certified and fellowship-trained surgeon, her extensive publications on surgical innovations lend credibility and authority to her advocacy for these technologies.

The 2025 Annual Clinical Assembly provides a platform for over 1,200 multi-disciplinary surgeons to engage in continuing medical education. Such gatherings are crucial for sharing knowledge on cutting-edge surgical techniques and innovations, including those presented by Perimeter Medical Imaging.

Perimeter’s approach to cancer surgery underscores the role of technology in modern medicine. Apart from the S-Series OCT, they are advancing the investigation of the Perimeter B-Series OCT, designed for enhanced imaging capabilities with artificial intelligence integration. Although currently under evaluation and investigational use, this next-generation device represents the commitment to improving breast cancer surgery outcomes.

The company's ticker symbol, “PINK,” serves as a nod to breast cancer awareness, reflecting both social responsibility and a mission-driven approach focused on addressing unmet medical needs. While the S-Series is FDA-cleared for general imaging, it's essential to highlight that its specific applications for breast cancer surgery are still pending evaluation for safety and effectiveness in the U.S.

In closing, Dr. Tower’s advocacy for surgical precision through advanced imaging technologies reinforces the ongoing evolution of surgical practices in the fight against breast cancer. Medical professionals eager to explore more regarding Perimeter’s offerings can engage through their official website for further information and resources. The journey toward enhanced surgical performance and patient outcomes continues as technologies push the boundaries of what’s possible in healthcare.